Related Experiment Videos
Cardiac imaging with technetium 99m-labeled isonitriles.
A J Sinusas1, G A Beller, D D Watson
1Cardiovascular Nuclear Imaging and Stress Laboratory, Yale University School of Medicine, New Haven, Connecticut.
Journal of Thoracic Imaging
|July 1, 1990
Summary
New technetium-99m-labeled isonitriles, like 99mTc-MIBI, show promise for myocardial perfusion imaging. These agents offer superior characteristics for assessing myocardial ischemia and infarction with SPECT.
Area of Science:
- Nuclear Medicine
- Cardiology
- Radiopharmaceutical Science
Background:
- 201Tl has limitations in myocardial perfusion imaging, especially with SPECT.
- 99mTc-labeled isonitriles represent a novel class of myocardial imaging agents.
- Superior physical characteristics of 99mTc-labeled agents may enhance imaging quality.
Purpose of the Study:
- To evaluate the potential of 99mTc-MIBI as a myocardial perfusion imaging agent.
- To assess the utility of 99mTc-MIBI in diagnosing myocardial ischemia and infarction.
- To explore the role of 99mTc-MIBI in evaluating therapeutic interventions for ischemic heart disease.
Main Methods:
- Initial experimental and clinical experience with 99mTc-MIBI.
- Assessment of myocardial risk area during acute coronary occlusion.
- Evaluation of myocardial salvage after reperfusion therapy.
Main Results:
- 99mTc-MIBI demonstrates promise for assessing myocardial ischemia and infarction.
- The agent can evaluate risk area and myocardial salvage noninvasively.
- Simultaneous assessment of myocardial perfusion and function is possible with 99mTc-MIBI.
Conclusions:
- 99mTc-MIBI offers a promising noninvasive approach for myocardial perfusion imaging.
- Further development of quantification algorithms and single-day protocols is needed.
- Encouraging initial results suggest potential for widespread clinical application after further studies.